Skip to main content
Hit enter to search or ESC to close
Dirk Thye, M.D.
Chief Executive Officer, Chief Medical Officer, and Board Member
Charles Ryan, J.D., Ph.D.
Brendan Hannah, M.B.A.
Chief Operating Officer & Chief Business Officer
Giovanni Mambrini, MSc
Chief Technology Officer
Thomas Sabia, M.B.A.
Chief Commercial Officer
Pamela Williamson, RAC, FRAPS, M.B.A
Head of Regulatory Affairs
Maureen Roden, M.S.N.
Vice President, Clinical Development
Gary Ward, Ph.D.
Vice President, CMC Management
Mary Ellen Sillivos, SPHR
Vice President, Human Resources
Vice President, Corporate Communications & Investor Relations
Board of Directors
President, En Pointe, LLC
Dirk Thye, M.D.
Chief Executive Officer, Quince Therapeutics
Luca Benatti, Ph.D.
Director, Newron Pharmaceuticals S.p.A, Intercept Pharmaceutical, and CasRevolution
Previously SVP, Global Regulatory Affairs and Medical Writing, Allergan
Margaret McLoughlin, Ph.D.
Previously Executive Director Worldwide Business Development, Pfizer
Rajiv Patni, M.D.
Former Reata Pharmaceuticals Chief Research & Development Officer
Una Ryan, OBE, Ph.D.
Previously Chief Executive Officer, AVANT Immunotherapeutics
Chief Financial Officer, Exelixis
Scientific Advisory Board
Mauro Magnani, Ph.D.
University of Urbino, Italy
Carlo Brugnara, M.D.
Harvard Medical School & Boston Children’s Hospital
William Jusko, Ph.D.
Buffalo University Jacobs School of Medicine and Biomedical Sciences
Howard Lederman, M.D., Ph.D.
Johns Hopkins University School of Medicine & Johns Hopkins Medical Center
Vladimir Muzykantov, M.D., Ph.D.
University of Pennsylvania, Philadelphia & Perelman School of Medicine, UPENN
Susan Perlman, M.D.
David Geffen School of Medicine at the University of California, Los Angeles & UCLA Health
James Spudich, Ph.D.
Stanford University School of Medicine
Sign up for email alerts
Please note our
. © 2024 Quince.